Seroprevalence of Toxoplasma gondii, Rubella, Group A Streptococcus, CMV and HSV-1 in COVID-19 Patients with Vitamin D Deficiency.
Pak J Biol Sci
; 24(11): 1169-1174, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1542850
ABSTRACT
<b>Background and Objective:
</b> In recent years, respiratory tract viral infections have caused many pandemics that impact the whole world. To investigate the seropositivity of <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> in recovered COVID-19 patients and correlate these findings with vitamin D levels. <b>Materials andMethods:
</b> A total of 417 COVID-19 patients with diarrhoea were enrolled in this study. Vitamin D and seroprevalence for <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> were evaluated and correlated. <b>Results:
</b> It was found that recent infection in COVID-19 patients with HSV-1, rubella, <i>Toxoplasma</i> and CMV, respectively. IgG was detected indicating the development of adaptive immunity with all microbes. <b>Conclusion:
</b> Current study detected a correlation between vitamin D levels and HSV-1 and no correlation between this infection and vitamin D deficiency with the other microbes.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vitamin D Deficiency
/
Calcifediol
/
Immunoglobulin G
/
Herpesvirus 1, Human
/
COVID-19 Serological Testing
/
COVID-19
/
Herpes Simplex
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Country/Region as subject:
Asia
Language:
English
Journal:
Pak J Biol Sci
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS